$1.96
0.115.95%
Last update: Dec 15, 11:31 AM
Comments
Loading...
Nautilus Biotechnology Earnings Estimates, EPS & Revenue | NASDAQ:NAUT | Benzinga
Nautilus Biotechnology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 26
EPS Estimate
$-0.140
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Nautilus Biotechnology using advanced sorting and filters.
Nautilus Biotechnology (NAUT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-28 | $-0.11 | $-0.15 | 26.7 % |
| Q2 | 2025-07-31 | $-0.12 | $-0.14 | 14.3 % |
| Q1 | 2025-04-29 | $-0.13 | $-0.14 | 7.14 % |
| Q4 | 2025-02-27 | $-0.14 | $-0.16 | 12.5 % |
Nautilus Biotechnology (NAUT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2022-05-03 | $0 | $170.00K | -100.0 % |
FAQ
When is Nautilus Biotechnology (NASDAQ:NAUT) reporting earnings?
Nautilus Biotechnology (NAUT) is scheduled to report earnings on February 26, 2026. The last reported earnings were for reported on October 28, 2025 for Q3.
What were the latest earnings per share (EPS) for Nautilus Biotechnology (NASDAQ:NAUT)?
The Actual EPS was $-0.11, which beat the estimate of $-0.15.
What were Nautilus Biotechnology’s (NASDAQ:NAUT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
